Xponance’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.6M | Buy |
58,323
+1,550
| +3% | +$628K | 0.2% | 81 |
|
2025
Q1 | $28.3M | Buy |
56,773
+35
| +0.1% | +$17.4K | 0.27% | 55 |
|
2024
Q4 | $29.5M | Buy |
56,738
+149
| +0.3% | +$77.5K | 0.27% | 53 |
|
2024
Q3 | $35M | Buy |
56,589
+881
| +2% | +$545K | 0.34% | 38 |
|
2024
Q2 | $30.8M | Sell |
55,708
-23,200
| -29% | -$12.8M | 0.31% | 43 |
|
2024
Q1 | $45.9M | Buy |
78,908
+2,147
| +3% | +$1.25M | 0.48% | 31 |
|
2023
Q4 | $40.7M | Buy |
76,761
+3,487
| +5% | +$1.85M | 0.49% | 30 |
|
2023
Q3 | $37.1M | Sell |
73,274
-981
| -1% | -$497K | 0.5% | 29 |
|
2023
Q2 | $38.7M | Buy |
74,255
+20,241
| +37% | +$10.6M | 0.52% | 29 |
|
2023
Q1 | $31.1M | Buy |
54,014
+1,285
| +2% | +$741K | 0.46% | 34 |
|
2022
Q4 | $29M | Buy |
52,729
+7,770
| +17% | +$4.28M | 0.47% | 32 |
|
2022
Q3 | $22.8M | Buy |
44,959
+3,432
| +8% | +$1.74M | 0.44% | 34 |
|
2022
Q2 | $22.6M | Sell |
41,527
-1,697
| -4% | -$922K | 0.45% | 34 |
|
2022
Q1 | $25.5M | Buy |
43,224
+503
| +1% | +$297K | 0.42% | 38 |
|
2021
Q4 | $28.5M | Buy |
42,721
+11,275
| +36% | +$7.52M | 0.45% | 35 |
|
2021
Q3 | $18M | Sell |
31,446
-1,981
| -6% | -$1.13M | 0.34% | 55 |
|
2021
Q2 | $16.9M | Sell |
33,427
-18,329
| -35% | -$9.25M | 0.31% | 65 |
|
2021
Q1 | $23.6M | Sell |
51,756
-217
| -0.4% | -$99K | 0.5% | 36 |
|
2020
Q4 | $24.2M | Buy |
51,973
+637
| +1% | +$297K | 0.53% | 34 |
|
2020
Q3 | $22.7M | Sell |
51,336
-2,405
| -4% | -$1.06M | 0.56% | 30 |
|
2020
Q2 | $19.5M | Buy |
+53,741
| New | +$19.5M | 0.5% | 32 |
|